| 摘要 |
<p>The present invention is directed to a method of treating restenosis, atherosclerosis or neointimal hyperplasia of vascular smooth muscle in a patient by administering known compounds which are useful as inhibitors of the Angiotensin II AT-2 receptor subtype.</p> |
